Biomedical Research
Documents
Emergency Use Authorization: In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Revocation
0 comments
Analysis in progress
Top issues in comments
Medical Devices: Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs Syndrome
0 comments
Analysis in progress
Top issues in comments
List of Bulk Drug Substances for which there Is a Clinical Need the Federal Food, Drug, and Cosmetic Act
0 comments
Analysis in progress
Top issues in comments
Medical Devices: Immunology and Microbiology Devices; Classification of the SARS-CoV-2 Serology Test
0 comments
Analysis in progress
Top issues in comments
Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Rectiv (Nitroglycerin) Ointment, 0.4 Percent
0 comments
Analysis in progress
Top issues in comments
Medical Devices: General Hospital and Personal Use Devices; Classification of the Foam or Gel Chemical Sterilant/High Level Disinfectant
0 comments
Analysis in progress
Top issues in comments
Medical Devices: Clinical Chemistry and Toxicology Devices; Classification of the Prognostic Test for Development or Progression of Preeclampsia
0 comments
Analysis in progress
Top issues in comments
Medical Devices: General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep System
0 comments
Analysis in progress
Top issues in comments
Medical Devices: General and Plastic Surgery Devices; Classification of the Breast Implant Suction Retrieval System
0 comments
Analysis in progress
Top issues in comments
Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation 7661
0 comments
Analysis in progress
Top issues in comments
Determination That Prednisolone Tablet, 5 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Proposed Collection; Comment Request; Time and Extent Applications for Nonprescription Drug Products
0 comments
Analysis in progress
Top issues in comments
